Detection of specific sequences in nucleic acids
AssigneeApplied Biosystems, LLC
InventorsNorman M. Whiteley, Michael W. Hunkapiller, Alexander N. Glazer
Life of this patent
Estimating the term…
Loading patent…
AssigneeApplied Biosystems, LLC
InventorsNorman M. Whiteley, Michael W. Hunkapiller, Alexander N. Glazer
Estimating the term…
The invention provides a method for diagnosis of genetic abnormalities or other genetic conditions which can be readily automated. The method is used to determine the presence or absence of a target sequence in a sample of denatured nucleic acid and entails hybridizing the sample with a probe complementary to a diagnostic portion of the target sequence (the diagnostic probe), and with a probe complementary to a nucleotide sequence contiguous with the diagnostic portion (the contiguous probe), under conditions wherein the diagnostic probe remains bound substantially only to the sample nucleic acid containing the target sequence. The diagnostic probe and contiguous probe are then covalently attached to yield a target probe which is complementary to the target sequence, and the probes which are not attached are removed. In the preferred mode, one of the probes is labeled so that the presence or absence of the target sequence can then be tested by melting the sample nucleic acid-target probe duplex, eluting the dissociated target probe, and testing for the label. In another embodiment, the testing is accomplished without first removing probes not covalently attached, by attaching a hook to the probe that is not labeled, so that the labeled target probe may be recovered by catching the hook. In both instances, the presence of both the diagnostic probe and the contiguous probe is required for the label to appear in the assay. The above method is then applied to the detection of genetic diseases.
A method of testing for the presence or absence of a target sequence in a sample containing DNA, the steps comprising:
A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid, which method comprises:
A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid using a diagnostic probe which is complementary to a diagnostic portion of the target sequence and a contiguous probe which is complementary to a portion of said target sequence which is contiguous with said diagnostic portion, wherein the diagnostic probe and the contiguous probe are of sufficient length that they can be stably hybridized to the target sequence long enough to be covalently attached to each other, and wherein one of the diagnostic probe and the contiguous probe will remain hybridized to the target sequence under a higher stringency than will the other, comprising the steps of:
A method of testing for the presence or absence of a target nucleotide sequence in a sample containing denatured nucleic acid, the steps comprising:
Dependencies are inferred from the claim text.